Efficacy of the Allosteric MEK Inhibitor Trametinib in Relapsed and Refractory Juvenile Myelomonocytic Leukemia: a Report from the Children's Oncology Group.
Article in Cancer Discovery (June 2024)
The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.
Article in Cancer Discovery (June 2024)
Article in PeerJ (January 2024)
Article in Journal of Immunology Research (August 2023)